Molecular pathogenesis of tuber formation in tuberous sclerosis complex.
about
The TSC1-TSC2 complex: a molecular switchboard controlling cell growthConvulsive seizures from experimental focal cortical dysplasia occur independently of cell misplacement.The tuberous sclerosis complex regulates trafficking of glucose transporters and glucose uptakeImpaired astrocytic gap junction coupling and potassium buffering in a mouse model of tuberous sclerosis complex.Single-cell Tsc1 knockout during corticogenesis generates tuber-like lesions and reduces seizure threshold in miceThe differential effects of prenatal and/or postnatal rapamycin on neurodevelopmental defects and cognition in a neuroglial mouse model of tuberous sclerosis complex.GABAergic interneuron development and function is modulated by the Tsc1 gene.A circuitry and biochemical basis for tuberous sclerosis symptoms: from epilepsy to neurocognitive deficitsBrain abnormalities in tuberous sclerosis complex.Activation of extracellular regulated kinase and mechanistic target of rapamycin pathway in focal cortical dysplasia.α-[¹¹C]-methyl-L-tryptophan PET for tracer localization of epileptogenic brain regions: clinical studies.Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways.The neural crest lineage as a driver of disease heterogeneity in Tuberous Sclerosis Complex and Lymphangioleiomyomatosis.Postnatal neurogenesis generates heterotopias, olfactory micronodules and cortical infiltration following single-cell Tsc1 deletion.Behavioral and cognitive aspects of tuberous sclerosis complex.Novel Histopathological Patterns in Cortical Tubers of Epilepsy Surgery Patients with Tuberous Sclerosis Complex.Newborn cortical neurons: only for neonates?Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function.Loss of Tsc2 in radial glia models the brain pathology of tuberous sclerosis complex in the mouse.The Tsc1-Tsc2 complex influences neuronal polarity by modulating TORC1 activity and SAD levels.Autism and mental retardation with convulsion in tuberous sclerosis: a case report.Mammalian target of rapamycin (mTOR) inhibition: potential for antiseizure, antiepileptogenic, and epileptostatic therapy.The natural history of epilepsy in tuberous sclerosis complex.Synaptic plasticity and learning in animal models of tuberous sclerosis complex.Neuronal and glia abnormalities in Tsc1-deficient forebrain and partial rescue by rapamycin.Conditional and domain-specific inactivation of the Tsc2 gene in neural progenitor cells.Zebrafish model of tuberous sclerosis complex reveals cell-autonomous and non-cell-autonomous functions of mutant tuberin.S6K1 regulates GSK3 under conditions of mTOR-dependent feedback inhibition of Akt.Purkinje cells derived from TSC patients display hypoexcitability and synaptic deficits associated with reduced FMRP levels and reversed by rapamycin.Characterization of autism in young children with tuberous sclerosis complex.Intrafamilial phenotypic variability in tuberous sclerosis complex.
P2860
Q24645204-6F4AE421-9999-4C89-AC7D-3AC030FBD54CQ27314858-17BD4562-D19B-4CB7-B30D-2B24A8FD6016Q28512637-140891F9-DA35-456B-B99F-A3F20CAE3731Q30491063-5508CD8F-5497-4176-BA79-7E209DE915A3Q30499302-6763D6A0-3141-4FFF-928E-3A1EF47D1EA9Q30518266-D21CAC5A-9373-4A5F-8C08-C54B349D1451Q30523993-A8098C93-AA60-4A61-A304-7E02AC62C1BBQ30597707-2E4B3954-3C49-4DB7-9CBF-87345D4D2EA8Q30977127-C6726F73-A50C-4A57-959E-1866BA5BCFC7Q33763506-2BB267BD-76F2-4CD0-B572-83C75228EF5CQ34049476-7E5244F3-CD73-4E86-943A-1EAEB3AB1142Q34562010-ECC8CDAB-ACD0-4E26-87CB-76DE9605EFCEQ34569989-31AC356A-9F62-4BAC-96BB-C69AE02614FDQ35688636-EA68A9A4-0BB8-4924-8DA6-99901B9A457EQ35962456-BF0D1423-FF1C-41C0-A881-3B62D6908534Q36050518-67383ECE-7D4D-44D0-8422-F16463F6FDF2Q36501255-82D7A079-F213-4EA2-BA9C-D28471FDB4CBQ37079765-1C1D6837-21CE-468E-991A-3C220B0D4821Q37128350-193FD828-C3FD-4217-91BA-F9DAD3983776Q37270207-83712BC1-9461-494F-8E47-224935B4CE28Q37338487-6CA7EBEA-674D-4E3A-B70C-8A412CC23F62Q37419781-A5AE46D0-229F-423B-95EF-D9ED86CD575DQ37664891-2E0EDDCF-756C-4F59-AE1C-9C6DD79AA5DDQ38030915-4FA06358-778B-406D-8BF3-4F7C1FD48733Q39425768-90C9E62F-BC68-403E-847A-2C9CFD753B14Q40022265-2C3CBF91-9C05-4FA1-BB96-BC92E12BF0DEQ42638137-2F07CA46-43E5-486A-9C43-6B189269AFCFQ42767363-468B8E36-E469-4B16-917A-164C966F7106Q49958432-1E26FC0A-2092-4AE9-9A57-80501FC28203Q50311253-E94D02EA-6B49-46A1-992F-574CE3A19893Q51895340-7C8503F1-4D5F-47D7-9DE0-4A6B478B5E11
P2860
Molecular pathogenesis of tuber formation in tuberous sclerosis complex.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Molecular pathogenesis of tuber formation in tuberous sclerosis complex.
@ast
Molecular pathogenesis of tuber formation in tuberous sclerosis complex.
@en
type
label
Molecular pathogenesis of tuber formation in tuberous sclerosis complex.
@ast
Molecular pathogenesis of tuber formation in tuberous sclerosis complex.
@en
prefLabel
Molecular pathogenesis of tuber formation in tuberous sclerosis complex.
@ast
Molecular pathogenesis of tuber formation in tuberous sclerosis complex.
@en
P2860
P1476
Molecular pathogenesis of tuber formation in tuberous sclerosis complex.
@en
P2093
Peter B Crino
P2860
P304
P356
10.1177/08830738040190091301
P577
2004-09-01T00:00:00Z